MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Genprex P/B Ratio 2011-2026 | GNPX
Annual P/B Ratio Genprex
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.381 | 0.044 | 2.6 | 5.14 | 8.91 | 2.28 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.91 | 0.044 | 3.22 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M |  USA |
 |
Verastem
VSTM
|
7.06 | $ 5.04 | -4.73 % | $ 349 M | USA |
 |
Voyager Therapeutics
VYGR
|
1.23 | $ 3.96 | -4.12 % | $ 232 M | USA |
 |
VistaGen Therapeutics
VTGN
|
1.04 | $ 0.57 | -5.87 % | $ 17.6 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | France |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
bluebird bio
BLUE
|
0.344 | - | - | $ 546 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
6.95 | - | - | $ 789 M | USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
11 | $ 12.41 | -11.1 % | $ 1.88 B | USA |
 |
Wave Life Sciences Ltd.
WVE
|
4.94 | $ 6.37 | 2.66 % | $ 1.07 B |  Singapore |
 |
Xenetic Biosciences
XBIO
|
0.591 | $ 2.72 | -2.86 % | $ 4.63 M | USA |
 |
XBiotech
XBIT
|
0.502 | $ 2.27 | -1.73 % | $ 69.2 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
3.97 | $ 54.48 | -1.89 % | $ 4.24 B | Canada |
 |
Xeris Pharmaceuticals
XERS
|
70.7 | $ 5.4 | -3.05 % | $ 866 M | USA |
 |
X4 Pharmaceuticals
XFOR
|
0.96 | $ 4.04 | -6.26 % | $ 171 M | USA |
 |
Xencor
XNCR
|
1.4 | $ 11.42 | -7.23 % | $ 848 M | USA |
 |
XOMA Corporation
XOMA
|
3.18 | $ 30.17 | -1.18 % | $ 364 M | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
22nd Century Group
XXII
|
0.0293 | $ 2.41 | -18.03 % | $ 444 K | USA |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
Cara Therapeutics
CARA
|
0.949 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
0.00635 | - | - | $ 3.74 B | USA |
 |
Zai Lab Limited
ZLAB
|
30.2 | $ 18.0 | 2.8 % | $ 19.7 B | China |
|
Enlivex Therapeutics Ltd.
ENLV
|
0.774 | $ 1.05 | -3.67 % | $ 21.5 M | Israel |
 |
Enochian Biosciences
ENOB
|
-5.41 | - | - | $ 40.5 M | USA |